TY  - JOUR
PY  - 2020//
TI  - Satisfaction with life following mild traumatic brain injury: a TRACK-TBI study
JO  - Journal of neurotrauma
A1  - Agtarap, Stephanie D.
A1  - Campbell-Sills, Laura
A1  - Jain, Sonia
A1  - Sun, Xiaoying
A1  - Dikmen, Sureyya
A1  - Levin, Harvey
A1  - McCrea, Michael
A1  - Mukherjee, Pratik
A1  - Nelson, Lindsay D.
A1  - Temkin, Nancy
A1  - Yuh, Esther Lim
A1  - Giacino, Joseph T.
A1  - Manley, Geoffrey T.
A1  - Investigators, The Track-Tbi
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - Identifying the principal determinants of life satisfaction following mild TBI (mTBI) may inform efforts to improve subjective well-being in this population. We examined life satisfaction among participants in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study who presented with mTBI (Glasgow Coma Scale=13-15; N=1,152). An L1-regularization path algorithm was used to select optimal sets of baseline and concurrent symptom measures for prediction of scores on the Satisfaction with Life Scale (SWLS) at 2 weeks and 3, 6, and 12 months post-injury. Multivariable linear regression models (ns=744-894) were then fit to evaluate associations between the empirically-selected predictors and SWLS scores at each follow-up visit. <br><br>RESULTS indicated that emotional post-TBI symptoms (b's= -1.27 to -0.77, ps<.05), anhedonia (b's = -1.59 to -1.08, ps<.01), and pain interference (b's= -1.38 to -0.89, ps<.001) contributed to the prediction of lower SWLS scores at all follow-ups. Insomnia predicted lower SWLS scores at 2 weeks, 3 months, and 6 months (b's= -1.11 to -0.83, ps<.01); and negative affect predicted lower SWLS scores at 2 weeks, 3 months, and 12 months (b's= -1.38 to -0.80, ps<.005). Other post-TBI symptom domains and baseline socio-demographic, injury-related, and clinical characteristics did not emerge as robust predictors of SWLS scores during the year after mTBI. Efforts to improve satisfaction with life following mTBI may benefit from a focus on the detection and treatment of affective symptoms, pain, and insomnia. The results reinforce the need for tailoring of evidence-based treatments for these conditions to maximize efficacy in patients with mTBI.<p />  <p>Language: en</p>
LA  - en
SN  - 0897-7151
UR  - http://dx.doi.org/10.1089/neu.2020.7055
ID  - ref1
ER  -